Clinical and laboratory features that differentiate familial from sporadic focal segmental glomerulosclerosis in adolescents and adults
release_p5rtfgyeyrdithpwcfmrkc3f2u
by
Maria Goretti Polito,
Michelle Tiveron Passos,
Danilo Euclides Fernandes,
Gianna Mastroianni-Kirsztajn
References
NOTE: currently batch computed and may include additional references sources, or be missing recent changes, compared to entity reference list.| Showing 1 - 17 of 17 references (in 82ms) | ||
|---|---|---|
[b0]via grobid |
Faubert PF, Porush JG. Familial focal segmental glomerulosclerosis: Nine cases in four families and review of the literature. Am J Kidney Dis. 1997; 30(2): 265-270.
| |
[b1]via grobid |
Conlon PJ, Lynn K, Winn MP, et al. Spectrum of disease in familial focal and segmental glomerulosclerosis. Kidney Int. 1999; 56(5): 1863- 1871.
| |
[b3]via grobid |
Frishberg Y, Rinat C, Megged O, et al. Mutations in NPHS2 encoding podocin are a prevalent cause of steroid-resistant nephrotic syndrome among Israeli-Arab children. J Am Soc Nephrol. 2002; 13(2): 400-405.
| |
[b4]via grobid |
Feltran LS, Varela P, Silva ED, et al. Targeted Next-Generation Sequencing in Brazilian Children With Nephrotic Syndrome Submitted to Renal Transplant. Transplantation. 2017; 101(12): 2905-2912.
| |
[b5]via grobid |
De Vriese AS, Sethi S, Nath KA, et al. Differentiating Primary, Genetic, and Secondary FSGS in Adults: A Clinicopathologic Approach. JASN. Published online January 10, 2018: ASN.2017090958. doi:10.1681/ ASN.2017090958
| |
[b6]via grobid |
Caridi G, Bertelli R, Carrea A, et al. Prevalence, genetics, and clinical features of patients carrying podocin mutations in steroid-resistant nonfamilial focal segmental glomerulosclerosis. J Am Soc Nephrol. 2001; 12(12): 2742-2746.
| |
[b7]via grobid |
Caridi G , Bertelli R, Di Duca M, et al. Broadening the Spectrum of Diseases Related to Podocin Mutations. J Am Soc Nephrol. 2003; 14(5): 1278-1286.
| |
[b8]via grobid |
Riguetti MTP, Varela P, Fernandes DE, et al. Familial Focal Segmental Glomerulosclerosis With Late-Onset Presentation and R229Q/ R291W Podocin Mutations. Front Genet. 2020; 11: 533373.
| |
[b9]via grobid |
Sanchez-Ares M, Garcia-Vidal M, Antucho E-E, et al. A novel mutation, outside of the candidate region for diagnosis, in the inverted formin 2 gene can cause focal segmental glomerulosclerosis. Kidney Int. 2013; 83(1): 153-159.
| |
[b10]via grobid |
Zhang Q, Ma J, Xie J, et al. Screening of ACTN4 and TRPC6 Mutations in a Chinese Cohort of Patients with Adult-Onset Familial Focal Segmental Glomerulosclerosis. Contrib Nephrol. 2013; 181: 91-100.
| |
[b11]via grobid |
Barua M, Brown EJ, Charoonratana VT, et al. Mutations in the INF2 gene account for a significant proportion of familial but not sporadic focal and segmental glomerulosclerosis. Kidney Int. 2013; 83(2): 316- 322.
| |
[b12]via grobid |
Kang HG, Ha I-S, Cheong HI. Recurrence and Treatment after Renal Transplantation in Children with FSGS. BioMed Res Int. 2016; 2016: 1-7.
| |
[b13]via grobid |
Faul C, Donnelly M, Merscher-Gomez S, et al. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med. 2008; 14(9): 931-938.
| |
[b14]via grobid |
Machuca E, Hummel A, Nevo F, et al. Clinical and epidemiological assessment of steroid-resistant nephrotic syndrome associated with the NPHS2 R229Q variant. Kidney Int. 2009; 75(7): 727-735.
| |
[b15]via grobid |
Büscher AK, Kranz B, Büscher R, et al. Immunosuppression and renal outcome in congenital and pediatric steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol. 2010; 5(11): 2075-2084.
| |
[b16]via grobid |
Yorgin PD, Belson A, Higgins J, et al. Pulse methylprednisolone, cyclosporine, and ACE inhibitor therapy decreases proteinuria in two siblings with familial focal segmental glomerulosclerosis. Am J Kidney Dis. 2001; 37(6): e44.1-e44.6.
| |
[b17]via grobid |
Monteiro EJ, Pereira AC, Pereira AB, et al. NPHS2 mutations in adult patients with primary focal segmental glomerulosclerosis. J Nephrol. 2006; 19(3): 366-371.
| |